These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12087603)

  • 41. Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors.
    Sáiz-Ruiz J; Ibáñez A; Díaz-Marsá M; Arias F; Padín J; Martín-Carrasco M; Montes JM; Ferrando L; Carrasco JL; Martín-Ballesteros E; Jordá L; Chamorro L
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1129-34. PubMed ID: 12452535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.
    Lenox-Smith AJ; Reynolds A
    Br J Gen Pract; 2003 Oct; 53(495):772-7. PubMed ID: 14601352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
    Nelson JC
    Depress Anxiety; 1998; 7 Suppl 1():5-6. PubMed ID: 9597344
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
    Einarson TR; Arikian SR; Casciano J; Doyle JJ
    Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Venlafaxine: not yet first in the antidepressant class.
    Harv Ment Health Lett; 2003 Apr; 19(10):5-7. PubMed ID: 12711568
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
    Khan A; Upton GV; Rudolph RL; Entsuah R; Leventer SM
    J Clin Psychopharmacol; 1998 Feb; 18(1):19-25. PubMed ID: 9472838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical evaluation of venlafaxine.
    Ballenger JC
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):29S-35S; discussion 35S-36S. PubMed ID: 8784646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A benefit-risk analysis of once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression.
    Entsuah R; Chitra R
    Psychopharmacol Bull; 1997; 33(4):671-6. PubMed ID: 9493478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Trazodone and venlafaxine in treatment of depressive disorders].
    Florkowski A; Gruszczyński W; Gałecki P; Zboralski K; Kołodziejska I; Mikołajczyk I
    Pol Merkur Lekarski; 2005 May; 18(107):556-9. PubMed ID: 16161955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases.
    Gonul AS; Akdeniz F; Donat O; Vahip S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):889-91. PubMed ID: 12921926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Venlafaxine: a new antidepressant drug.
    Holdcroft C
    Nurse Pract; 1994 Sep; 19(9):21. PubMed ID: 7816367
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
    Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
    Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
    Asarnow JR; Emslie G; Clarke G; Wagner KD; Spirito A; Vitiello B; Iyengar S; Shamseddeen W; Ritz L; Birmaher B; Ryan N; Kennard B; Mayes T; DeBar L; McCracken J; Strober M; Suddath R; Leonard H; Porta G; Keller M; Brent D
    J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):330-339. PubMed ID: 19182688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antidepressant options: venlafaxine in perspective.
    Thase ME
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):10S-18S; discussion 18S-20S. PubMed ID: 8784644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regarding "Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs".
    Koesters M; Becker T; Weinmann S
    Biol Psychiatry; 2009 Sep; 66(5):e7; authour reply e9-10. PubMed ID: 19520365
    [No Abstract]   [Full Text] [Related]  

  • 57. A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK.
    Wade AG; Toumi I; Hemels ME
    Curr Med Res Opin; 2005 Apr; 21(4):631-42. PubMed ID: 15899113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
    Rush AJ; Trivedi MH; Wisniewski SR; Stewart JW; Nierenberg AA; Thase ME; Ritz L; Biggs MM; Warden D; Luther JF; Shores-Wilson K; Niederehe G; Fava M;
    N Engl J Med; 2006 Mar; 354(12):1231-42. PubMed ID: 16554525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of venlafaxine extended release formulation on the clinical management of patients].
    Carrasco JL; Díaz-Marsá M; López-Ibor JJ
    Actas Esp Psiquiatr; 2005; 33(3):147-53. PubMed ID: 15918081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.